Therefore, inhibition of microglial IL-1β and astrocytic 5-HTT, or specific activation of 5-HT1A receptor could be promising ways to ameliorate the various symptoms of CFS, at least in infection-related cases. The gene discussed is SLC6A4; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.